 Life Science Investor Mandates (Sept. 10 - Sept. 16) |
| |
|
Invests In Regenerative Medicine Globally
|
Seeks Early Stage Life Science Companies in the US & China
|
|
Seeks Therapeutic Opportunities In US, EU, Canada
|
|
Seeks Early-Stage Medical Devices
|
|
RESI Innovation Challenge Winners Announced
|
Life Science Nation and MaRS Collaborate with Johnson & Johnson Innovation, JLABS to Host RESI Conference in Toronto
|
|
|
 |
By Nono Hu, Senior Manager, Branding & Messaging, LSN
Yesterday, the sixth Redefining Early Stage Investments (RESI) Conference was held at the Westin Copley Place, Boston. Featuring approximately 200 investors, 250 biotech, medtech and healthcare IT entrepreneurs, and 130 service providers, this event is the biggest RESI ever.
In the exhibit hall, 30 of the most innovative early stage life science companies at the event were chosen to participate in a virtual investment contest - The RESI Innovation Challenge, showcasing cutting-edge life science technologies in poster displays and competing to raise the most RESI Cash. Without further ado here are the top 3 contestants!
First Prize Winner: Rna Diagnostics
As a first prize winner, Rna Diagnostics will receive complimentary subscription to the LSN Investor Platform.
|
| |
Alejandro Zamorano, Director of Business Development, LSN | John Connolly, VP Corporate Development, Rna Diagnostics | Michael Quigley, Director of Research, LSN
|
Second Prize Winner: KIYATEC
As a second prize winner, KIYATEC will receive two complimentary RESI tickets.
|
| |
Alejandro Zamorano, Director of Business Development, LSN | Todd Haim, Program Director, SBIR Development Center, NCI | Matthew Gevaert, CEO, KIYATEC | Bryce Chaney, Senior Director of BD, KIYATEC | Michael Quigley, Director of Research, LSN
|
Third Prize Winner: Synthonics
As a third prize winner, Synthonics will receive one complimentary RESI ticket.
|
| |
Alejandro Zamorano, Director of Business Development, LSN | John Borling, Board Member, Synthonics | Michael Quigley, Director of Research, LSN
|
|
 |
|
Life Science Nation (LSN) and MaRS Discovery District (MaRS) are collaborating with Johnson & Johnson Innovation, JLABS (JLABS) to bring the Redefining Early Stage Investments (RESI) Conference to Toronto on June 23, 2016.
The RESI Conference series brings together fundraising CEOs and early stage investors from around the globe, providing the opportunity for dialogue and relationship building, with the goal of eventual capital allocations...
"MaRS supports over 250 Canadian-grown early stage health technology startups," said Dr. Zayna Khayat, Lead, MaRS Health. "Our goal is to provide these young emerging ventures with the best connections to investors and industry to help them scale internationally. The Redefining Early Stage Investments (RESI) conference series has a strong track record of attracting global early stage investors. We're delighted to bring them to MaRS in 2016 to build on the success of our HealthKick conferences and support new technologies that will achieve better health outcomes...
|
|
|
|
|
|
